Molecular Therapy Family of Journals (@MolTherapy) header
Molecular Therapy Family of Journals (@MolTherapy) profile picture

The leading family of journals in cell and gene therapy. Journals include Molecular Therapy, Advances, Nucleic Acids, and Oncology.

Joined February 2014
Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)Photo by Molecular Therapy Family of Journals (@MolTherapy)
Decoupling Efficacy from Toxicity: Engineering Spatial Control in AAV-Mediated Gene Therapy dlvr.​it/TWMKxm #MTMCD
4
2
5
188
The antileukemic efficacy of CAR-NK cells is shaped by clonal expression of inhibitory KIRs and patient-encoded KIR ligands dlvr.​it/TWM3t6 #MTMCD
124
AAV9-PMM2 therapy rescues neuronal phenotypes in a human cortical organoid model of PMM2-CDG dlvr.​it/TWLb0X #MTMCD
1
2
7
322
Automated Ex Vivo Processing Enables Lentiviral Transduction and Preserves Stemness in Human CD34+ Hematopoietic Stem and Progenitor Cells dlvr.​it/TWKlHS #MTMCD
3
5
353
Postnatal gene restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD) reveals phenotype reversibility dlvr.​it/TWKVmM #MTMCD
153
A Parametric Study of AAV-PHP.​eB for CNS Gene Transfer in C57BL/6J Mice: Transduction Kinetics, Safety Profiles, and Applications dlvr.​it/TWK64g #MTMCD
156
Neutralizing antibodies against 20 different AAV variants are rare in human cerebrospinal fluid despite high seroprevalences. dlvr.​it/TWK5yK #MTMCD
2
226
From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy dlvr.​it/TWK5sM #MTMCD
1
149
Nucleic Acid Therapeutics for Treating Glioblastoma: From Modality and Delivery Design to Scalable Nanomedicine Platforms dlvr.​it/TWK5jq #MTNA
1
1
184
Anti-microRNA-378a Enhances Wound Healing Process by Upregulating Integrin Beta-3 and Vimentin dlvr.​it/TWJxgV #genetherapy #celltherapy
1
148
FLT3 Kinase Inhibition Reshapes the Neuronal Transcriptome to Suppress Seizures dlvr.​it/TWJt9d #genetherapy #celltherapy
1
156
A dendritic cell-targeting LNP hybridized with multi-antigen cell membrane for precision cancer immunotherapy dlvr.​it/TWJt6J #genetherapy #celltherapy
1
3
6
364
Clinically relevant AAV8-PEX1 gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorder dlvr.​it/TWJmLp #genetherapy #celltherapy
143
Hyaluronan accumulation mediated by Human Identical Sequences provides a broad-spectrum therapeutic strategy against virulent coronaviruses dlvr.​it/TWJmJx #MTNA
1
165
A Novel Human iPSC-derived Liver Model for In Vitro Assessment of AAV Gene Therapies dlvr.​it/TWJmGr #MTMCD
2
4
290
A Streamlined AAV Purification Process via Engineered Affinity Tag-Assisted Liquid-Liquid Phase Separation dlvr.​it/TWJKfF #MTMCD
1
4
190
Validation of an agonistic canine anti-CD3ε antibody for the production of metabolically fit T cells for adoptive therapy dlvr.​it/TWJKWl #MTMCD
2
2
164
Cryo-EM Mapping of Human Neutralizing Antibodies Reveals 3-fold Antigenic “Hotspot” on the AAV2 Capsid dlvr.​it/TWJKPB #MTMCD
3
220
A single-nucleotide change in the Kozak sequence enhances protein expression from IVT mRNA dlvr.​it/TWJKN8 #MTNA
2
12
616
LILRB1 as a novel therapeutic target for CAR-T therapy in diffuse large B cell lymphoma dlvr.​it/TWJ8mz #genetherapy #celltherapy
2
2
176